Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1673 - 1680 of 11454 results
DOJ Crackdown on Genetic Testing Telefraud
August 15, 2022| News
CDC Shifts Approach and Loosens COVID-19 Quarantine Recommendations, including for Most Workplaces
August 15, 2022| Blog| Viewpoint
'Unprecedented Times': A Power Shortage In Data Center Alley Has Developers Scrambling
August 14, 2022| News
Enforcing Patents Isn't Easier As America Invents Act Turns 10
August 12, 2022| News
A Stranger's Guide to USITC Trade Secret Complaints
August 12, 2022| News
Climate Disclosure Opens up Litigation Path
August 11, 2022| News
California Voters Will Decide PAGA’s Fate at the Ballot Box in 2024
August 10, 2022| Blog| Viewpoint
HIPAA Faces Test in New Abortion Reality
August 10, 2022| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.